Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study
Titel:
Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study
Auteur:
Moreau, Philippe Pylypenko, Halyna Grosicki, Sebastian Karamanesht, Ievgenii Leleu, Xavier Grishunina, Maria Rekhtman, Grigoriy Masliak, Zvenyslava Robak, Tadeusz Shubina, Anna Arnulf, Bertrand Kropff, Martin Cavet, James Esseltine, Dixie-Lee Feng, Huaibao Girgis, Suzette van de Velde, Helgi Deraedt, William Harousseau, Jean-Luc